Bank Of New York Mellon Corp Age X Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	BUY	$1.25 - $1.82 $4,148 - $6,040	3,319 Added 5.74%	61,157 $111,000
Q3 2019 Nov 07, 2019	SELL	$1.96 - $3.38 $9,555 - $16,477	-4,875 Reduced 7.77%	57,838 $113,000
Q2 2019 Aug 12, 2019	BUY	$2.58 - $4.92 $45,106 - $86,016	17,483 Added 38.65%	62,713 $230,000
Q1 2019 May 14, 2019	SELL	$3.0 - $4.85 $2,196 - $3,550	-732 Reduced 1.59%	45,230 $183,000
Q4 2018 Feb 11, 2019	BUY	$2.49 - $5.5 $114,445 - $252,791	45,962 New	45,962 $137,000

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.